7TM Pharma has received an undisclosed milestone payment in their research collaboration with Ortho-McNeil-Janssen Pharmaceuticals, Inc. (“Ortho-McNeil”). The milestone was triggered by successful progress in selecting a pre-clinical candidate for the treatment of asthma and allergy.
